Journal article · 2021 · Open access

Reporting of Patient-Reported Outcomes for Psoriasis in FDA Drug Labels, Medical Reviews, and Trial Publications: 2006-2019

Kyungwan Hong, S. Seo

Value in Health, 24, S93 · Published 1 June 2021 · DOI 10.1016/j.jval.2021.04.485

Open full textCite this paper

In brief

“Reporting of Patient-Reported Outcomes for Psoriasis in FDA Drug Labels, Medical Reviews, and Trial Publications: 2006-2019” is a 2021 journal article by Kyungwan Hong and S. Seo, published in Value in Health. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read at Value in Health.

Citations
0
Authors
2

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hong, K., & Seo, S. (2021). Reporting of Patient-Reported Outcomes for Psoriasis in FDA Drug Labels, Medical Reviews, and Trial Publications: 2006-2019. Value in Health, 24, S93. https://doi.org/10.1016/j.jval.2021.04.485

MLA 9

Hong, Kyungwan, and S. Seo. “Reporting of Patient-Reported Outcomes for Psoriasis in FDA Drug Labels, Medical Reviews, and Trial Publications: 2006-2019.” Value in Health, vol. 24, 2021, p. S93. https://doi.org/10.1016/j.jval.2021.04.485.

Chicago

Hong, Kyungwan and S. Seo. 2021. “Reporting of Patient-Reported Outcomes for Psoriasis in FDA Drug Labels, Medical Reviews, and Trial Publications: 2006-2019.” Value in Health 24: S93. https://doi.org/10.1016/j.jval.2021.04.485.

Harvard

Hong, K. and Seo, S. (2021) ‘Reporting of Patient-Reported Outcomes for Psoriasis in FDA Drug Labels, Medical Reviews, and Trial Publications: 2006-2019’, Value in Health, 24, p. S93. doi:10.1016/j.jval.2021.04.485.

IEEE

K. Hong and S. Seo, “Reporting of Patient-Reported Outcomes for Psoriasis in FDA Drug Labels, Medical Reviews, and Trial Publications: 2006-2019,” Value in Health, vol. 24, p. S93, 2021, doi: 10.1016/j.jval.2021.04.485.

BibTeX

@article{hong2021reporting,
  title     = {{Reporting of Patient-Reported Outcomes for Psoriasis in FDA Drug Labels, Medical Reviews, and Trial Publications: 2006-2019}},
  author    = {Hong, Kyungwan and Seo, S.},
  journal   = {Value in Health},
  year      = {2021},
  volume    = {24},
  pages     = {S93},
  doi       = {10.1016/j.jval.2021.04.485},
  url       = {https://doi.org/10.1016/j.jval.2021.04.485}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis

  • patient-reported outcomes
  • psoriasis
  • psoriatic arthritis
  • FDA drug labeling
  • reporting discrepancies
  • Biologics License Application
  • new chemical entities
  • ClinicalTrials.gov

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Hong, K., & Seo, S. (2021). Reporting of Patient-Reported Outcomes for Psoriasis in FDA Drug Labels, Medical Reviews, and Trial Publications: 2006-2019. Value in Health, 24, S93. https://doi.org/10.1016/j.jval.2021.04.485

How many times has this paper been cited?

0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Value in Health: sign in and open the full text from this page.

Who wrote this paper?

Kyungwan Hong, S. Seo.

What is the DOI of this paper?

10.1016/j.jval.2021.04.485, permanently at https://doi.org/10.1016/j.jval.2021.04.485. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.